4 unknown. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 2 | Unknown 2 |
Follow Soft-tissue Sarcoma: new trials by email Literature Review of Soft-tissue Sarcoma trials Research Report on Soft-tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors Phase 1 : Regorafenib, Phase 1 : Avelumab, Phase 2 : Regorafenib - Colorectal Cancer Not MSI-H or MMR-deficient, GIST | Phase 1 / Phase 2 | Unknown | Institut BergoniƩ | 747 | 2018-05-04 | 2023-03-03 |
| Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. Palbociclib - Soft-tissue Sarcoma, Osteosarcoma | Phase 2 | Unknown | Grupo Espanol de Investigacion en Sarcomas | 40 | 2017-03-31 | 2024-01-23 |
| A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Ribociclib - Liposarcomas, Dedifferentiated, Liposarcoma - Well Differentiated | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 30 | 2016-07-01 | 2017-10-25 |
| A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) Cyclophosphamide and JX-594 dose escalation, Cyclophosphamide and JX-594, Cyclophosphamide - Solid Tumors, Soft-tissue Sarcoma | Phase 1 / Phase 2 | Unknown | Institut BergoniƩ | 197 | 2015-09-18 | 2022-02-02 |
Sarcoma (4) · Biliary Tract Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Chordoma (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Lipoma (1) · Liposarcoma (1) · Liposarcoma, Myxoid (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Osteosarcoma (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Connective and Soft Tissue (4) · Breast Diseases (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1) · Adenoma (1) · Biliary Tract Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Digestive System Diseases (1)
Clinical Trials, Phase II as Topic (1) · Cyclophosphamide (1) · avelumab (1) · palbociclib (1) · regorafenib (1) · ribociclib (1)
Institut BergoniĆ© (2) · Assaf-Harofeh Medical Center (1) · Grupo Espanol de Investigacion en Sarcomas (1)
France (2) · Israel (1) · Spain (1)
Anna Estival (1) · Antonio Casado (1) · Claudia Valverde (1) · Daniela Katz, M.D (1) · Diego Jara, MD (1) · Isabel Sevilla, MD (1) · Javier Lavernia (1) · Josefina Cruz (1)
PMID 34965951, PMID 34998048, PMID 40204996, PMID 40579407
2014 (1), 2016 (1)